Vaccines Clinical Trials: Active Studies by Market and Country

• 36markets with active trials
• 410active studies on Cancer Vaccines
• 40of our places with active trials

Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

1. 1Cancer Vaccines410Cancer Vaccines: See them on ClinicalTrials.gov (opens in a new tab)
2. 2mRNA Therapeutics169mRNA Therapeutics: See them on ClinicalTrials.gov (opens in a new tab)
3. 3HPV Vaccines129HPV Vaccines: See them on ClinicalTrials.gov (opens in a new tab)
4. 4HPV Vaccination99HPV Vaccination: See them on ClinicalTrials.gov (opens in a new tab)
5. 5Adult Immunisation81Adult Immunisation: See them on ClinicalTrials.gov (opens in a new tab)
6. 6RSV Vaccines73RSV Vaccines: See them on ClinicalTrials.gov (opens in a new tab)
7. 7Influenza Vaccination72Influenza Vaccination: See them on ClinicalTrials.gov (opens in a new tab)
8. 8Pneumococcal Vaccines71Pneumococcal Vaccines: See them on ClinicalTrials.gov (opens in a new tab)
9. 9Shingles Vaccines66Shingles Vaccines: See them on ClinicalTrials.gov (opens in a new tab)
10. 10Dengue Vaccines52Dengue Vaccines: See them on ClinicalTrials.gov (opens in a new tab)
11. 11COVID-19 Vaccination44COVID-19 Vaccination: See them on ClinicalTrials.gov (opens in a new tab)
12. 12Malaria Vaccines33Malaria Vaccines: See them on ClinicalTrials.gov (opens in a new tab)
13. 13Pertussis (Whooping Cough)31Pertussis (Whooping Cough): See them on ClinicalTrials.gov (opens in a new tab)
14. 14Monkeypox (Mpox) Vaccines and Treatments28Monkeypox (Mpox) Vaccines and Treatments: See them on ClinicalTrials.gov (opens in a new tab)
15. 15Pneumococcal Vaccination27Pneumococcal Vaccination: See them on ClinicalTrials.gov (opens in a new tab)
16. 16Maternal Immunisation23Maternal Immunisation: See them on ClinicalTrials.gov (opens in a new tab)
17. 17Diphtheria22Diphtheria: See them on ClinicalTrials.gov (opens in a new tab)
18. 18Measles19Measles: See them on ClinicalTrials.gov (opens in a new tab)
19. 19Vaccine Hesitancy15Vaccine Hesitancy: See them on ClinicalTrials.gov (opens in a new tab)
20. 20Yellow Fever15Yellow Fever: See them on ClinicalTrials.gov (opens in a new tab)
21. 21Mpox Vaccination11Mpox Vaccination: See them on ClinicalTrials.gov (opens in a new tab)
22. 22Dengue Vaccination10Dengue Vaccination: See them on ClinicalTrials.gov (opens in a new tab)
23. 23RSV Maternal Vaccination9RSV Maternal Vaccination: See them on ClinicalTrials.gov (opens in a new tab)
24. 24Childhood Immunisation8Childhood Immunisation: See them on ClinicalTrials.gov (opens in a new tab)
25. 25Typhoid Conjugate Vaccine6Typhoid Conjugate Vaccine: See them on ClinicalTrials.gov (opens in a new tab)
26. 26Rabies Post-Exposure Prophylaxis5Rabies Post-Exposure Prophylaxis: See them on ClinicalTrials.gov (opens in a new tab)
27. 27Ebola Vaccination4Ebola Vaccination: See them on ClinicalTrials.gov (opens in a new tab)
28. 28Japanese Encephalitis4Japanese Encephalitis: See them on ClinicalTrials.gov (opens in a new tab)
29. 29Measles-Rubella Vaccination4Measles-Rubella Vaccination: See them on ClinicalTrials.gov (opens in a new tab)
30. 30Oral Cholera Vaccination3Oral Cholera Vaccination: See them on ClinicalTrials.gov (opens in a new tab)
31. 31Immunisation Data Systems2Immunisation Data Systems: See them on ClinicalTrials.gov (opens in a new tab)
32. 32Hepatitis B Birth Dose Vaccination1Hepatitis B Birth Dose Vaccination: See them on ClinicalTrials.gov (opens in a new tab)
33. 33Maternal and Neonatal Tetanus1Maternal and Neonatal Tetanus: See them on ClinicalTrials.gov (opens in a new tab)
34. 34Rotavirus Vaccination1Rotavirus Vaccination: See them on ClinicalTrials.gov (opens in a new tab)
35. 35Vaccine Cold Chain1Vaccine Cold Chain: See them on ClinicalTrials.gov (opens in a new tab)
36. 36Vaccine Manufacturing in Africa1Vaccine Manufacturing in Africa: See them on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

• Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

  NCT06472245Cancer Vaccines

• Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery

  NCT00669734Cancer Vaccines

• Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer

  NCT04270149Cancer Vaccines

• Phase I Trial of a Single Administration of aKLmRNA-Mediated Protein Replacement Therapy

  NCT07544420mRNA Therapeutics

• Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

  NCT07665515mRNA Therapeutics

• A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1

  NCT04534205mRNA Therapeutics

• Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls

  NCT00867464HPV Vaccines

• Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)

  NCT07756840HPV Vaccines

• Persistence of Immune Response Six Years After One Dose of 9vHPV Vaccine Among Male and Female Students

  NCT07156084HPV Vaccines

• The Mother-Daughter Project: Merck-4

  NCT07240220HPV Vaccination

• Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Challenge Agent and Evaluate Transmission in Mosquito Feeding Assays

  NCT06607003Adult Immunisation

• Multi-peptide Vaccination Adjuvanted With XS15 in Acute Myeloid Leukemia Patients

  NCT06252584Adult Immunisation

• Conversational AI for Adult Flu Vaccination Decisions

  NCT07896850Adult Immunisation

• Immunogenicity and Safety of SYS6057 in the Participants Aged 18 Years and Above

  NCT07925775RSV Vaccines

• Study to Learn About a Respiratory Syncytial Virus Vaccine in Children at High Risk of RSV Disease

  NCT07839871RSV Vaccines

• A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease

  NCT07220109RSV Vaccines

• A Study to Evaluate the Safety of Subunit Influenza Vaccine in People Aged 6 Months and Older

  NCT07933458Influenza Vaccination

• SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI

  NCT05869968Influenza Vaccination

• A Study to Assess the Safety, Tolerability, and Immunogenicity of 3 Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to Adults

  NCT07794748Pneumococcal Vaccines

• A Study to Learn About How a New Pneumococcal Vaccine Works in Infants

  NCT06524414Pneumococcal Vaccines

• A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants

  NCT07573462Pneumococcal Vaccines

• Clinical Trial of Recombinant Herpes Zoster Vaccine (ZFA01 Adjuvant, CHO Cells)

  NCT07920172Shingles Vaccines

• Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) in Healthy Chinese Population Aged 40 Years and Older

  NCT06851832Shingles Vaccines

• Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population

  NCT05580458Shingles Vaccines

Source: ClinicalTrials.gov, Study records, newest update first. Retrieved 12 Nov 2026.

• Measles vaccine
• DTP3 vaccine
• Measles vaccine, 2nd dose
• HPV vaccine (girls)

• Infectious diseases
• Pediatric
• Respiratory
• Maternal
• Oncology
• Animal health
• Women's health
• Malaria
• Biologics and biosimilars
• Neonatal